ArticleBritish journal of cancer2023

NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.

Sara Witting Christensen Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.